Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)
Won‐Tak Choi, Srinivas Duggineni, Yan Xu, et al.
Journal of Medicinal Chemistry (2011) Vol. 55, Iss. 3, pp. 977-994
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

The Intricate Role of CXCR4 in Cancer
Samit Chatterjee, Babak Behnam Azad, Sridhar Nimmagadda
Advances in cancer research (2014), pp. 31-82
Open Access | Times Cited: 587
Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
Anup K. Singh, Rakesh Kumar Arya, Arun Kumar Trivedi, et al.
Cytokine & Growth Factor Reviews (2012) Vol. 24, Iss. 1, pp. 41-49
Open Access | Times Cited: 181
Design of a Novel Cyclotide-Based CXCR4 Antagonist with Anti-Human Immunodeficiency Virus (HIV)-1 Activity
Teshome Leta Aboye, Helen Ha, Subhabrata Majumder, et al.
Journal of Medicinal Chemistry (2012) Vol. 55, Iss. 23, pp. 10729-10734
Open Access | Times Cited: 123
CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
Ashraf Sadat Mousavi
Immunology Letters (2019) Vol. 217, pp. 91-115
Closed Access | Times Cited: 119
Zinc Complexes with Nitrogen Donor Ligands as Anticancer Agents
Marina Porchia, Maura Pellei, Fabio Del Bello, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5814-5814
Open Access | Times Cited: 118
Regioselective synthesis of isoxazole–mercaptobenzimidazole hybrids and their in vivo analgesic and anti-inflammatory activity studies
Shravankumar Kankala, Ranjith Kumar Kankala, Prasad Gundepaka, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 5, pp. 1306-1309
Closed Access | Times Cited: 115
Crystal Structures of Protein-Bound Cyclic Peptides
Alpeshkumar K. Malde, Timothy A. Hill, Abishek Iyer, et al.
Chemical Reviews (2019) Vol. 119, Iss. 17, pp. 9861-9914
Closed Access | Times Cited: 87
CXCR4/CXCL12 axis: “old” pathway as “novel” target for anti‐inflammatory drug discovery
Liuxin Lu, Junjie Li, Xiaoying Jiang, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 3, pp. 1189-1220
Closed Access | Times Cited: 14
Recent advancement in pyrrolidine moiety for the management of cancer: A review
Rakesh Sahu, Kamal Shah, Rishabha Malviya, et al.
Results in Chemistry (2024) Vol. 7, pp. 101301-101301
Open Access | Times Cited: 13
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Chemokine Receptor Antagonists
James E. Pease, Richard Horuk
Journal of Medicinal Chemistry (2012) Vol. 55, Iss. 22, pp. 9363-9392
Closed Access | Times Cited: 100
Discovery and Characterization of an Endogenous CXCR4 Antagonist
Onofrio Zirafi, Kyeong-Ae Kim, Ludger Ständker, et al.
Cell Reports (2015) Vol. 11, Iss. 5, pp. 737-747
Open Access | Times Cited: 89
Imaging agents for the chemokine receptor 4 (CXCR4)
Joeri Kuil, Tessa Buckle, Fijs W. B. van Leeuwen
Chemical Society Reviews (2012) Vol. 41, Iss. 15, pp. 5239-5239
Closed Access | Times Cited: 80
Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity
Jean Dam, Zeenat Ismail, Taurai Kurebwa, et al.
European Journal of Medicinal Chemistry (2016) Vol. 126, pp. 353-368
Closed Access | Times Cited: 74
Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists
Valarie M. Truax, Huanyu Zhao, Brooke M. Katzman, et al.
ACS Medicinal Chemistry Letters (2013) Vol. 4, Iss. 11, pp. 1025-1030
Open Access | Times Cited: 58
Current trends in epigenetic, cellular and molecular pathways in management of rheumatoid arthritis
Rashita Makkar, Aayush Sehgal, Sukhbir Singh, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1577-1588
Closed Access | Times Cited: 13
Small molecule and peptide CXCR4 antagonists. A patent review from 2019 to 2024
Zafer Şahin, Yesim A. Tahirovic, Jiafeng Geng, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Structural mechanisms underlying the modulation of CXCR4 by diverse small-molecule antagonists
Xiaohong Sang, Haizhan Jiao, Qian Meng, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
A Conformationally Frozen Peptoid Boosts CXCR4 Affinity and Anti‐HIV Activity
Oliver Demmer, Andreas O. Frank, Franz Hagn, et al.
Angewandte Chemie International Edition (2012) Vol. 51, Iss. 32, pp. 8110-8113
Closed Access | Times Cited: 50
Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis
Stefanie Thiele, Jignesh Mungalpara, Anne Steen, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 23, pp. 5313-5329
Open Access | Times Cited: 42
Small molecule and peptide-based CXCR4 modulators as therapeutic agents. A patent review for the period from 2010 to 2018
Yesim A. Tahirovic, Sameshnee Pelly, Edgars Jēčs, et al.
Expert Opinion on Therapeutic Patents (2019) Vol. 30, Iss. 2, pp. 87-101
Closed Access | Times Cited: 41
Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology
Lun K. Tsou, Ying‐Huey Huang, Jen‐Shin Song, et al.
Medicinal Research Reviews (2017) Vol. 38, Iss. 4, pp. 1188-1234
Closed Access | Times Cited: 36
In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent
Wojciech G. Lesniak, Teshome Leta Aboye, Samit Chatterjee, et al.
Chemistry - A European Journal (2017) Vol. 23, Iss. 58, pp. 14469-14475
Open Access | Times Cited: 36
Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases
Jatinder Singh, Ramanpreet Shah, Dhandeep Singh
International Immunopharmacology (2016) Vol. 40, pp. 362-384
Closed Access | Times Cited: 35
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists
Pandian Sokkar, Mirja Harms, Christina M. Stürzel, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top